-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Adma Biologics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2012 to 2024.
- Adma Biologics, Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2024 was -$3.61M, a 88.7% increase year-over-year.
- Adma Biologics, Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2024 was -$13.3M, a 73.4% increase year-over-year.
- Adma Biologics, Inc. annual Nonoperating Income (Expense) for 2024 was -$13.3M, a 73.4% increase from 2023.
- Adma Biologics, Inc. annual Nonoperating Income (Expense) for 2023 was -$49.9M, a 87.9% decline from 2022.
- Adma Biologics, Inc. annual Nonoperating Income (Expense) for 2022 was -$26.5M, a 99.9% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)